Correlation Between Praxis Precision and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Praxis Precision and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and Pieris Pharmaceuticals.
Diversification Opportunities for Praxis Precision and Pieris Pharmaceuticals
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Praxis and Pieris is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Praxis Precision i.e., Praxis Precision and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Praxis Precision and Pieris Pharmaceuticals
Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.87 times more return on investment than Pieris Pharmaceuticals. However, Praxis Precision Medicines is 1.14 times less risky than Pieris Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 3,210 in Praxis Precision Medicines on August 24, 2024 and sell it today you would earn a total of 4,096 from holding Praxis Precision Medicines or generate 127.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Praxis Precision Med |
| Pieris Pharmaceuticals |
Praxis Precision and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and Pieris Pharmaceuticals
The main advantage of trading using opposite Praxis Precision and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Praxis Precision vs. ZyVersa Therapeutics | Praxis Precision vs. Sonnet Biotherapeutics Holdings | Praxis Precision vs. Zura Bio Limited | Praxis Precision vs. Phio Pharmaceuticals Corp |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world |